	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31	TTM Jun 30

Period length: Source:	12M PR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR	12M IR
Total Revenue	99.43	213.45	255.55	111.32	91.93	109.66	146.96	153.13
Cost of Operating Revenue	65.02	99.91	134.26	78.11	62.98	70.53	94.96	97.28
Gross Profit	34.41	113.55	121.28	33.21	28.95	39.13	52.00	55.85
Gross Margin	34.6	53.2	47.5	29.8	31.5	35.7	35.4	36.5
Total Operating Expenses	90.11	152.33	201.52	128.72	104.50	119.54	140.42	142.65
Operating Profit	9.32	61.12	54.03	-17.40	-12.57	-9.88	6.54	10.48
Operating Margin	9.4	28.6	21.1	-15.6	-13.7	-9.0	4.5	6.8
Financing Income/(Expense) - Net	-0.71	1.11	6.04	3.95	3.92	6.92	5.95	-1.24
Profit before Taxes	8.61	62.33	60.98	-10.74	-2.54	1.34	4.98	8.18
Income Taxes	2.21	15.96	16.02	-2.49	-0.75	0.50	2.90	3.84
Profit after Tax	6.40	46.37	44.96	-8.25	-1.79	0.85	2.08	4.34
PAT Margin	6.4	21.7	17.6	-7.4	-2.0	0.8	1.4	2.8
EPS - Basic - ex Extraordinary Items	6.39	46.37	44.96	-8.25	-1.79	0.85	2.11	4.84
EPS - Diluted - ex Extraordinary Items	6.39	46.37	44.96	-8.25	-1.79	0.85	2.11	4.84
EBIT	9.32	61.12	54.03	-17.40	-12.57	-9.88	6.54	10.48
EBITDA	9.69	61.54	55.51	-15.01	-10.21	-7.54	8.56	12.57
EBITDA Margin	9.7	28.8	21.7	-13.5	-11.1	-6.9	5.8	8.2

Balance Sheet

Abridged

Understanding Balance Sheet

Nureca Ltd. balance sheet covering assets, liabilities, equity and borrowings across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31

Source:	PR	AR	AR	AR	AR	AR	AR
Total Current Assets	32.75	181.12	206.19	186.56	192.59	189.95	114.68
Long-Term Investments	0.03	0.10	2.22	7.24	-	3.50	63.43
Property Plant & Equipment - Net	1.06	3.68	7.80	6.04	5.08	7.01	11.88
Total Non-Current Assets	1.13	4.63	12.94	20.02	12.57	20.02	81.48
Total Assets	33.88	185.75	219.13	206.58	205.17	209.98	196.16
Total Current Liabilities	9.50	18.87	12.24	8.88	9.27	12.40	13.78
Long Term Debt	9.35	3.34	3.28	2.03	1.81	2.59	0.83
Total Non-Current Liabilities	9.45	3.79	3.69	2.81	2.78	3.29	1.62
Total Liabilities	18.95	22.65	15.93	11.70	12.05	15.69	15.40
Total Shareholders' Equity	14.93	163.10	203.20	194.88	193.11	194.28	180.76
Total Equity	14.93	163.10	203.20	194.88	193.11	194.28	180.76
Total Liabilities & Equity	33.88	185.75	219.13	206.58	205.17	209.98	196.16

Cash Flow

Abridged

Understanding Cash Flow Statement

Nureca Ltd. cash flow statement covering operating, investing and financing activities across annual and quarterly periods.

Consolidated

Standalone

Annual

Interim

	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31

Period length: Source:	12M PR	12M AR	12M AR	12M AR	12M AR	12M AR	12M AR
Operating CF bef Changes in Working Cap	9.25	46.69	42.90	-17.26	1.16	-1.99	15.57
Working Capital - Increase/(Decrease)	-17.69	-12.51	-37.90	28.59	5.34	-10.46	-7.18
Net CF from Operating Activities	-8.44	34.18	5.01	11.34	6.50	-12.45	8.39
Capital Expenditures - Net	0.41	0.73	6.00	0.40	1.09	2.29	6.41
Net CF from Investing Activities	-0.41	-110.18	-7.13	-17.68	7.88	0.82	8.12
Dividends Paid - Cash - Total	-	-	4.99	-	-	-	-
Stock - Issuance/(Retirement) - Net	-	105.00	-	-	-	-	-15.67
Debt - LT & ST - Issuance/(Retirement) - Total	8.81	-8.61	-1.88	-1.40	-0.82	0.82	-2.61
Net Cash Flow from Financing Activities	8.81	93.16	-6.87	-1.40	-0.82	0.82	-18.28
Free Cash Flow to Equity	-0.04	24.84	-2.87	9.55	4.59	-13.92	-0.64
Free Operating CF net dividend	-8.85	33.45	-5.99	10.94	5.41	-14.76	1.56
Free Operating CF	-8.85	33.45	-0.99	10.94	5.41	-14.76	1.56

Business Segment Analysis

FY End:

Mar 26

Nureca Ltd. business segment breakdown covering revenue, operating income and assets across key divisions for the selected financial year.

Capex

Home healthcare and Wellness Products (100.0%)₹ 6.83 Cr

Revenue / Sales

Home healthcare and Wellness Products (100.0%)₹ 146.96 Cr

Assets

Home healthcare and Wellness Products (100.0%)₹ 196.16 Cr

Operating Income

Home healthcare and Wellness Products (100.0%)₹ 6.54 Cr

Regional Segment Analysis

FY End:

Mar 26

Nureca Ltd. geographic revenue split showing domestic and international market performance across revenue and income for the selected financial year.

Revenue / Sales

India (99.9%)₹ 146.83 CrOutside India (0.1%)₹ 0.14 Cr

Historical Segment Analysis

Track how Nureca Ltd. segment contributions have evolved over multiple financial years to see which divisions are growing, shrinking or gaining strategic importance.

Capex

Sales

Assets

Operating Income

Business

Regional

Business

	2020 Mar 31	2021 Mar 31	2022 Mar 31	2023 Mar 31	2024 Mar 31	2025 Mar 31	2026 Mar 31

Home healthcare and Wellness Products	0	1	6	0	1	2	7

Frequently Asked Questions

What is the revenue of Nureca Ltd.?

The latest trailing twelve month revenue of Nureca Ltd. is ₹ 153.13 Cr, reflecting a 1-year growth of 23.92% and a 3-year CAGR of 12.68%. Annual and quarterly revenue trends are available in the Income Statement section.

What is the net profit of Nureca Ltd.?

The latest trailing twelve month net profit (PAT) of Nureca Ltd. is ₹ 4.34 Cr. Detailed profit history across annual and quarterly periods is in the Income Statement section.

What is the EBITDA of Nureca Ltd.?

The trailing twelve month EBITDA of Nureca Ltd. is approximately ₹ 10.48 Cr (based on an operating margin of 6.84%). EBITDA reflects core operating profitability before interest, taxes, depreciation and amortisation.

What is the EPS of Nureca Ltd.?

The trailing twelve month Earnings Per Share (EPS) of Nureca Ltd. is 4.84. EPS trends across annual and quarterly periods are visible in the Income Statement section.

What is the debt level of Nureca Ltd.?

The debt-to-equity ratio of Nureca Ltd. stands at 0.01. The interest coverage ratio is 8.48x, reflecting the company's ability to service debt from operating earnings. The full breakdown of total borrowings is in the Balance Sheet section.

What is the book value per share of Nureca Ltd.?

The estimated book value per share of Nureca Ltd. is 189.44 (derived from a P/B ratio of 1.79 and market price of ₹ 340.00), reflecting the net asset value attributable to each share. See the Balance Sheet section for a full breakdown.

What is the cash flow from operations of Nureca Ltd.?

The trailing twelve month operating cash flow of Nureca Ltd. is ₹ 8.39 Cr. Annual and quarterly cash flow data is available in the Cash Flow section of the Statements tab.

Does Nureca Ltd. report consolidated or standalone financials?

Nureca Ltd. reports consolidated financials. You can toggle between consolidated and standalone views using the switch at the top of each statement section.